AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 O
< 20 21 20 21 O
2.5 21 24 21 24 B-upper_bound
X 25 26 25 26 I-upper_bound
institutional 27 40 27 40 I-upper_bound
upper 41 46 41 46 I-upper_bound
limit 47 52 47 52 I-upper_bound
of 53 55 53 55 I-upper_bound
normal 56 62 56 62 I-upper_bound

Age 0 3 63 66 B-age
> 4 5 67 68 O
18 5 7 68 70 B-lower_bound
years 8 13 71 76 I-lower_bound

History 0 7 77 84 O
of 8 10 85 87 O
allergic 11 19 88 96 O
reactions 20 29 97 106 O
attributed 30 40 107 117 O
to 41 43 118 120 O
compounds 44 53 121 130 B-allergy_name
of 54 56 131 133 I-allergy_name
similar 57 64 134 141 I-allergy_name
chemical 65 73 142 150 I-allergy_name
or 74 76 151 153 I-allergy_name
biologic 77 85 154 162 I-allergy_name
composition 86 97 163 174 I-allergy_name
to 98 100 175 177 I-allergy_name
monocolonal 101 112 178 189 I-allergy_name
antibodies 113 123 190 200 I-allergy_name
from 124 128 201 205 I-allergy_name
Murine 129 135 206 212 I-allergy_name
sources 136 143 213 220 I-allergy_name

History 0 7 221 228 O
of 8 10 229 231 O
corticosteroid 11 25 232 246 B-treatment
use 26 29 247 250 O
in 30 32 251 253 O
the 33 36 254 257 O
four 37 41 258 262 B-upper_bound
weeks 42 47 263 268 I-upper_bound
preceding 48 57 269 278 O
entry 58 63 279 284 O
onto 64 68 285 289 O
the 69 72 290 293 O
clinical 73 81 294 302 B-treatment
trial 82 87 303 308 I-treatment
, 87 88 308 309 O
or 89 91 310 312 O
the 92 95 313 316 O
requirement 96 107 317 328 O
for 108 111 329 332 O
ongoing 112 119 333 340 O
corticosteroid 120 134 341 355 O
use 135 138 356 359 O
during 139 145 360 366 O
the 146 149 367 370 O
study 150 155 371 376 O
period 156 162 377 383 O

If 0 2 384 386 O
patients 3 11 387 395 O
have 12 16 396 400 O
had 17 20 401 404 O
recent 21 27 405 411 O
surgery 28 35 412 419 B-treatment
, 35 36 419 420 O
then 37 41 421 425 O
they 42 46 426 430 O
must 47 51 431 435 O
be 52 54 436 438 O
fully 55 60 439 444 O
recovered 61 70 445 454 O
from 71 75 455 459 O
the 76 79 460 463 O
effects 80 87 464 471 O
of 88 90 472 474 O
that 91 95 475 479 O
surgery 96 103 480 487 O

Karnofsky 0 9 488 497 B-clinical_variable
performance 10 21 498 509 I-clinical_variable
status 22 28 510 516 I-clinical_variable
must 29 33 517 521 O
be 34 36 522 524 O
> 37 38 525 526 O
70 38 40 526 528 B-lower_bound
% 40 41 528 529 I-lower_bound

Life 0 4 530 534 B-clinical_variable
expectancy 5 15 535 545 I-clinical_variable
of 16 18 546 548 O
greater 19 26 549 556 O
than 27 31 557 561 O
three 32 37 562 567 B-lower_bound
months 38 44 568 574 I-lower_bound

Ontak 0 5 575 580 B-treatment
administration 6 20 581 595 O
and/or 21 27 596 602 O
vaccine 28 35 603 610 B-treatment
therapy 36 43 611 618 I-treatment
will 44 48 619 623 O
commence 49 57 624 632 O
at 58 60 633 635 O
least 61 66 636 641 O
4 67 68 642 643 B-lower_bound
weeks 69 74 644 649 I-lower_bound
after 75 80 650 655 O
the 81 84 656 659 O
completion 85 95 660 670 O
of 96 98 671 673 O
the 99 102 674 677 O
last 103 107 678 682 O
day 108 111 683 686 O
of 112 114 687 689 O
any 115 118 690 693 O
of 119 121 694 696 O
the 122 125 697 700 O
aforementioned 126 140 701 715 O
therapies 141 150 716 725 B-treatment

Patients 0 8 726 734 O
are 9 12 735 738 O
eligible 13 21 739 747 O
after 22 27 748 753 O
tumor 28 33 754 759 B-cancer
collection 34 44 760 770 O
for 45 48 771 774 O
the 49 52 775 778 O
vaccine 53 60 779 786 B-treatment
strategy 61 69 787 795 I-treatment
, 69 70 795 796 O
or 71 73 797 799 O
for 74 77 800 803 O
those 78 83 804 809 O
selected 84 92 810 818 O
to 93 95 819 821 O
receive 96 103 822 829 O
ONTAK 104 109 830 835 B-treatment
alone 110 115 836 841 O
( 116 117 842 843 O
group 117 122 843 848 O
3 123 124 849 850 O
) 124 125 850 851 O
because 126 133 852 859 O
tumor 134 139 860 865 O
is 140 142 866 868 O
not 143 146 869 872 O
available 147 156 873 882 O
can 157 160 883 886 O
enroll 161 167 887 893 O
at 168 170 894 896 O
ay 171 173 897 899 O
time 174 178 900 904 O
they 179 183 905 909 O
fulfill 184 191 910 917 O
the 192 195 918 921 O
Eligibility 196 207 922 933 O
Criteria 208 216 934 942 O

Patients 0 8 943 951 O
may 9 12 952 955 O
not 13 16 956 959 O
be 17 19 960 962 O
receiving 20 29 963 972 O
any 30 33 973 976 O
other 34 39 977 982 O
investigational 40 55 983 998 B-treatment
agents 56 62 999 1005 I-treatment

Patients 0 8 1006 1014 O
must 9 13 1015 1019 O
have 14 18 1020 1024 O
a 19 20 1025 1026 O
histologic 21 31 1027 1037 O
or 32 34 1038 1040 O
cytologic 35 44 1041 1050 O
diagnosis 45 54 1051 1060 O
of 55 57 1061 1063 O
epithelial 58 68 1064 1074 B-cancer
ovarian 69 76 1075 1082 I-cancer
cancer 77 83 1083 1089 I-cancer

Patients 0 8 1090 1098 O
must 9 13 1099 1103 O
not 14 17 1104 1107 O
have 18 22 1108 1112 O
received 23 31 1113 1121 O
any 32 35 1122 1125 O
antineoplastic 36 50 1126 1140 B-treatment
chemotherapy 51 63 1141 1153 I-treatment
or 64 66 1154 1156 O
immunotherapy 67 80 1157 1170 B-treatment
for 81 84 1171 1174 O
the 85 88 1175 1178 O
four 89 93 1179 1183 B-upper_bound
weeks 94 99 1184 1189 I-upper_bound
preceding 100 109 1190 1199 O
tumor 110 115 1200 1205 B-cancer
excision 116 124 1206 1214 O

Patients 0 8 1215 1223 O
must 9 13 1224 1228 O
not 14 17 1229 1232 O
have 18 22 1233 1237 O
received 23 31 1238 1246 O
irradiation 32 43 1247 1258 B-treatment
for 44 47 1259 1262 O
the 48 51 1263 1266 O
four 52 56 1267 1271 B-upper_bound
weeks 57 62 1272 1277 I-upper_bound
prior 63 68 1278 1283 I-upper_bound
to 69 71 1284 1286 O
removal 72 79 1287 1294 O
of 80 82 1295 1297 O
the 83 86 1298 1301 O
tumor 87 92 1302 1307 B-cancer
and 93 96 1308 1311 O
no 97 99 1312 1314 O
previously 100 110 1315 1325 O
irradiated 111 121 1326 1336 O
tumor 122 127 1337 1342 O
deposits 128 136 1343 1351 O
may 137 140 1352 1355 O
be 141 143 1356 1358 O
used 144 148 1359 1363 O
for 149 152 1364 1367 O
tumor 153 158 1368 1373 O
lysate 159 165 1374 1380 O
in 166 168 1381 1383 O
the 169 172 1384 1387 O
development 173 184 1388 1399 O
of 185 187 1400 1402 O
the 188 191 1403 1406 O
dendritic 192 201 1407 1416 B-treatment
cell 202 206 1417 1421 I-treatment
vaccine 207 214 1422 1429 I-treatment

Patients 0 8 1430 1438 O
to 9 11 1439 1441 O
be 12 14 1442 1444 O
randomized 15 25 1445 1455 O
to 26 28 1456 1458 O
groups 29 35 1459 1465 O
1 36 37 1466 1467 O
and 38 41 1468 1471 O
2 42 43 1472 1473 O
must 44 48 1474 1478 O
have 49 53 1479 1483 O
tumor 54 59 1484 1489 B-cancer
available 60 69 1490 1499 O
for 70 73 1500 1503 O
preparation 74 85 1504 1515 O
of 86 88 1516 1518 O
tumor 89 94 1519 1524 B-treatment
lysate 95 101 1525 1531 I-treatment
vaccine 102 109 1532 1539 I-treatment

Patients 0 8 1540 1548 O
who 9 12 1549 1552 O
are 13 16 1553 1556 O
expected 17 25 1557 1565 O
to 26 28 1566 1568 O
require 29 36 1569 1576 O
therapeutic 37 48 1577 1588 B-treatment
anticoagulation 49 64 1589 1604 I-treatment
during 65 71 1605 1611 O
the 72 75 1612 1615 O
trial 76 81 1616 1621 O
period 82 88 1622 1628 O

Patients 0 8 1629 1637 O
who 9 12 1638 1641 O
have 13 17 1642 1646 O
had 18 21 1647 1650 O
chemotherapy 22 34 1651 1663 B-treatment
or 35 37 1664 1666 O
radiotherapy 38 50 1667 1679 B-treatment
within 51 57 1680 1686 O
4 58 59 1687 1688 O
weeks 60 65 1689 1694 O
( 66 67 1695 1696 O
6 67 68 1696 1697 B-upper_bound
weeks 69 74 1698 1703 I-upper_bound
for 75 78 1704 1707 O
nitrosoureas 79 91 1708 1720 B-treatment
or 92 94 1721 1723 O
mitomycin 95 104 1724 1733 B-treatment
C 105 106 1734 1735 I-treatment
) 106 107 1735 1736 O
prior 108 113 1737 1742 O
to 114 116 1743 1745 O
entering 117 125 1746 1754 O
the 126 129 1755 1758 O
study 130 135 1759 1764 O
or 136 138 1765 1767 O
those 139 144 1768 1773 O
who 145 148 1774 1777 O
have 149 153 1778 1782 O
not 154 157 1783 1786 O
recovered 158 167 1787 1796 O
from 168 172 1797 1801 O
adverse 173 180 1802 1809 O
events 181 187 1810 1816 O
due 188 191 1817 1820 O
to 192 194 1821 1823 O
agents 195 201 1824 1830 O
administered 202 214 1831 1843 O
more 215 219 1844 1848 O
than 220 224 1849 1853 O
4 225 226 1854 1855 O
weeks 227 232 1856 1861 O
earlier 233 240 1862 1869 O

Patients 0 8 1870 1878 O
who 9 12 1879 1882 O
have 13 17 1883 1887 O
received 18 26 1888 1896 O
prior 27 32 1897 1902 B-treatment
anti 33 37 1903 1907 I-treatment
- 37 38 1907 1908 I-treatment
tumor 38 43 1908 1913 I-treatment
vaccines 44 52 1914 1922 I-treatment
are 53 56 1923 1926 O
ineligible 57 67 1927 1937 O

Patients 0 8 1938 1946 O
with 9 13 1947 1951 O
known 14 19 1952 1957 O
brain 20 25 1958 1963 B-cancer
metastases 26 36 1964 1974 I-cancer

Pre 0 3 1975 1978 O
- 3 4 1978 1979 O
vaccination 4 15 1979 1990 B-treatment
the 16 19 1991 1994 O
goal 20 24 1995 1999 O
is 25 27 2000 2002 O
to 28 30 2003 2005 O
establish 31 40 2006 2015 O
a 41 42 2016 2017 O
Minimal 43 50 2018 2025 B-cancer
Residual 51 59 2026 2034 I-cancer
Disease 60 67 2035 2042 I-cancer
state 68 73 2043 2048 O
( 74 75 2049 2050 O
MRD 75 78 2050 2053 B-cancer
maximum 79 86 2054 2061 O
tumor 87 92 2062 2067 B-cancer
diameter 93 101 2068 2076 O
of 102 104 2077 2079 O
any 105 108 2080 2083 O
residual 109 117 2084 2092 O
disease 118 125 2093 2100 O
â‰¤ 126 127 2101 2102 O
1 128 129 2103 2104 B-upper_bound
cm 129 131 2104 2106 I-upper_bound
) 131 132 2106 2107 O

Pregnant 0 8 2108 2116 B-pregnancy
and 9 12 2117 2120 O
lactating 13 22 2121 2130 O
women 23 28 2131 2136 B-gender
are 29 32 2137 2140 O
excluded 33 41 2141 2149 O
from 42 46 2150 2154 O
this 47 51 2155 2159 O
study 52 57 2160 2165 O

Should 0 6 2166 2172 O
a 7 8 2173 2174 O
woman 9 14 2175 2180 B-gender
become 15 21 2181 2187 B-pregnancy
pregnant 22 30 2188 2196 I-pregnancy
or 31 33 2197 2199 O
suspect 34 41 2200 2207 B-pregnancy
she 42 45 2208 2211 I-pregnancy
is 46 48 2212 2214 I-pregnancy
pregnant 49 57 2215 2223 I-pregnancy
while 58 63 2224 2229 O
participating 64 77 2230 2243 O
in 78 80 2244 2246 O
this 81 85 2247 2251 O
study 86 91 2252 2257 O
, 91 92 2257 2258 O
she 93 96 2259 2262 O
should 97 103 2263 2269 O
inform 104 110 2270 2276 O
her 111 114 2277 2280 O
treating 115 123 2281 2289 O
physician 124 133 2290 2299 O
immediately 134 145 2300 2311 O

The 0 3 2312 2315 O
effects 4 11 2316 2323 O
of 12 14 2324 2326 O
Ontak 15 20 2327 2332 B-treatment
on 21 23 2333 2335 O
the 24 27 2336 2339 O
developing 28 38 2340 2350 O
human 39 44 2351 2356 O
fetus 45 50 2357 2362 O
at 51 53 2363 2365 O
the 54 57 2366 2369 O
recommended 58 69 2370 2381 O
therapeutic 70 81 2382 2393 O
dose 82 86 2394 2398 O
are 87 90 2399 2402 O
unknown 91 98 2403 2410 O

The 0 3 2411 2414 O
following 4 13 2415 2424 O
labs 14 18 2425 2429 O
must 19 23 2430 2434 O
be 24 26 2435 2437 O
drawn 27 32 2438 2443 O
within 33 39 2444 2450 O
four 40 44 2451 2455 B-upper_bound
weeks 45 50 2456 2461 I-upper_bound
of 51 53 2462 2464 O
having 54 60 2465 2471 O
the 61 64 2472 2475 O
tumor 65 70 2476 2481 B-cancer
harvested 71 80 2482 2491 O
and/or 81 87 2492 2498 O
receiving 88 97 2499 2508 O
the 98 101 2509 2512 O
dose 102 106 2513 2517 O
of 107 109 2518 2520 O
Ontak 110 115 2521 2526 B-treatment

This 0 4 2527 2531 O
can 5 8 2532 2535 O
be 9 11 2536 2538 O
achieved 12 20 2539 2547 O
with 21 25 2548 2552 O
surgery 26 33 2553 2560 B-treatment
and/or 34 40 2561 2567 O
salvage 41 48 2568 2575 B-treatment
chemotherapy 49 61 2576 2588 I-treatment

Uncontrolled 0 12 2589 2601 O
intercurrent 13 25 2602 2614 B-chronic_disease
illness 26 33 2615 2622 I-chronic_disease
including 34 43 2623 2632 O
, 43 44 2632 2633 O
but 45 48 2634 2637 O
not 49 52 2638 2641 O
limited 53 60 2642 2649 O
to 61 63 2650 2652 O
, 63 64 2652 2653 O
ongoing 65 72 2654 2661 O
or 73 75 2662 2664 O
active 76 82 2665 2671 B-chronic_disease
infection 83 92 2672 2681 I-chronic_disease
, 92 93 2681 2682 O
active 94 100 2683 2689 B-chronic_disease
bleeding 101 109 2690 2698 I-chronic_disease
, 109 110 2698 2699 O
symptomatic 111 122 2700 2711 O
congestive 123 133 2712 2722 B-chronic_disease
heart 134 139 2723 2728 I-chronic_disease
failure 140 147 2729 2736 I-chronic_disease
, 147 148 2736 2737 O
unstable 149 157 2738 2746 B-chronic_disease
angina 158 164 2747 2753 I-chronic_disease
pectoris 165 173 2754 2762 I-chronic_disease
, 173 174 2762 2763 O
cardiac 175 182 2764 2771 B-chronic_disease
arrhythmia 183 193 2772 2782 I-chronic_disease
, 193 194 2782 2783 O
uncontrolled 195 207 2784 2796 O
bronchospasm 208 220 2797 2809 B-chronic_disease
, 220 221 2809 2810 O
hypertension 222 234 2811 2823 B-chronic_disease
, 234 235 2823 2824 O
hyperglycemia 236 249 2825 2838 B-chronic_disease
, 249 250 2838 2839 O
or 251 253 2840 2842 O
hypercalcemia 254 267 2843 2856 B-chronic_disease
; 267 268 2856 2857 O
or 269 271 2858 2860 O
psychiatric 272 283 2861 2872 B-chronic_disease
illness 284 291 2873 2880 I-chronic_disease
/ 291 292 2880 2881 O
social 292 298 2881 2887 B-chronic_disease
situations 299 309 2888 2898 I-chronic_disease
that 310 314 2899 2903 O
in 315 317 2904 2906 O
the 318 321 2907 2910 O
opinion 322 329 2911 2918 O
of 330 332 2919 2921 O
the 333 336 2922 2925 O
investigators 337 350 2926 2939 O
would 351 356 2940 2945 O
compromise 357 367 2946 2956 O
the 368 371 2957 2960 O
patient 372 379 2961 2968 O
's 379 381 2968 2970 O
ability 382 389 2971 2978 O
to 390 392 2979 2981 O
tolerate 393 401 2982 2990 O
this 402 406 2991 2995 O
treatment 407 416 2996 3005 B-treatment
or 417 419 3006 3008 O
affect 420 426 3009 3015 O
compliance 427 437 3016 3026 O

Women 0 5 3027 3032 B-gender
and 6 9 3033 3036 O
members 10 17 3037 3044 O
of 18 20 3045 3047 O
all 21 24 3048 3051 O
races 25 30 3052 3057 O
and 31 34 3058 3061 O
ethnic 35 41 3062 3068 O
groups 42 48 3069 3075 O
are 49 52 3076 3079 O
eligible 53 61 3080 3088 O
for 62 65 3089 3092 O
this 66 70 3093 3097 O
trial 71 76 3098 3103 O

Women 0 5 3104 3109 B-gender
of 6 8 3110 3112 O
child 9 14 3113 3118 O
- 14 15 3118 3119 O
bearing 15 22 3119 3126 O
potential 23 32 3127 3136 O
must 33 37 3137 3141 O
agree 38 43 3142 3147 B-contraception_consent
to 44 46 3148 3150 I-contraception_consent
use 47 50 3151 3154 I-contraception_consent
adequate 51 59 3155 3163 I-contraception_consent
contraception 60 73 3164 3177 I-contraception_consent
( 74 75 3178 3179 O
hormonal 75 83 3179 3187 B-contraception_consent
or 84 86 3188 3190 O
barrier 87 94 3191 3198 B-contraception_consent
method 95 101 3199 3205 I-contraception_consent
of 102 104 3206 3208 I-contraception_consent
birth 105 110 3209 3214 I-contraception_consent
control 111 118 3215 3222 I-contraception_consent
; 118 119 3222 3223 O
abstinence 120 130 3224 3234 B-contraception_consent
) 130 131 3234 3235 O
prior 132 137 3236 3241 O
to 138 140 3242 3244 O
study 141 146 3245 3250 O
entry 147 152 3251 3256 O
and 153 156 3257 3260 O
for 157 160 3261 3264 O
the 161 164 3265 3268 O
duration 165 173 3269 3277 O
of 174 176 3278 3280 O
study 177 182 3281 3286 O
participation 183 196 3287 3300 O

absolute 0 8 3301 3309 B-clinical_variable
lymphocyte 9 19 3310 3320 I-clinical_variable
count 20 25 3321 3326 I-clinical_variable
> 26 27 3327 3328 O
500 28 31 3329 3332 B-lower_bound
/ 31 32 3332 3333 I-lower_bound
mm3 32 35 3333 3336 I-lower_bound

absolute 0 8 3337 3345 B-clinical_variable
neutrophil 9 19 3346 3356 I-clinical_variable
count 20 25 3357 3362 I-clinical_variable
> 26 27 3363 3364 O
1,000 28 33 3365 3370 B-lower_bound
/ 33 34 3370 3371 I-lower_bound
mm3 34 37 3371 3374 I-lower_bound

albumin 0 7 3375 3382 B-clinical_variable
> 8 9 3383 3384 O
3.0 9 12 3384 3387 B-lower_bound
mg 13 15 3388 3390 I-lower_bound
/ 15 16 3390 3391 I-lower_bound
dl 16 18 3391 3393 I-lower_bound

creatinine 0 10 3394 3404 B-clinical_variable
â‰¤2.0 11 15 3405 3409 O
mg 16 18 3410 3412 I-upper_bound
/ 18 19 3412 3413 I-upper_bound
dl 19 21 3413 3415 I-upper_bound

no 0 2 3416 3418 O
dosing 3 9 3419 3425 O
or 10 12 3426 3428 O
adverse 13 20 3429 3436 O
event 21 26 3437 3442 O
data 27 31 3443 3447 O
are 32 35 3448 3451 O
currently 36 45 3452 3461 O
available 46 55 3462 3471 O
on 56 58 3472 3474 O
the 59 62 3475 3478 O
use 63 66 3479 3482 O
of 67 69 3483 3485 O
Ontak 70 75 3486 3491 B-treatment
in 76 78 3492 3494 O
combination 79 90 3495 3506 O
with 91 95 3507 3511 O
dendritic 96 105 3512 3521 B-treatment
cell 106 110 3522 3526 I-treatment
vaccination 111 122 3527 3538 I-treatment
in 123 125 3539 3541 O
patients 126 134 3542 3550 O
< 135 136 3551 3552 O
18 136 138 3552 3554 B-upper_bound
years 139 144 3555 3560 I-upper_bound
of 145 147 3561 3563 O
age 148 151 3564 3567 B-age

platelet 0 8 3568 3576 B-clinical_variable
count 9 14 3577 3582 I-clinical_variable
> 15 16 3583 3584 O
80,000 17 23 3585 3591 B-lower_bound
/ 23 24 3591 3592 I-lower_bound
mm3 24 27 3592 3595 I-lower_bound

prothrombin 0 11 3596 3607 B-clinical_variable
time 12 16 3608 3612 I-clinical_variable
( 17 18 3613 3614 I-clinical_variable
INR 18 21 3614 3617 I-clinical_variable
) 21 22 3617 3618 I-clinical_variable
â‰¤1.5 23 27 3619 3623 O
X 28 29 3624 3625 I-upper_bound
institutional 30 43 3626 3639 I-upper_bound
upper 44 49 3640 3645 I-upper_bound
limit 50 55 3646 3651 I-upper_bound
of 56 58 3652 3654 I-upper_bound
normal 59 65 3655 3661 I-upper_bound

requirements 0 12 3662 3674 O
for 13 16 3675 3678 O
vaccine 17 24 3679 3686 B-treatment
therapy 25 32 3687 3694 I-treatment
initiation 33 43 3695 3705 O

six 0 3 3706 3709 B-upper_bound
weeks 4 9 3710 3715 I-upper_bound
for 10 13 3716 3719 O
nitrosoureas 14 26 3720 3732 B-treatment
and 27 30 3733 3736 O
mitomycin 31 40 3737 3746 B-treatment
- 40 41 3746 3747 I-treatment
C 41 42 3747 3748 I-treatment

there 0 5 3749 3754 O
is 6 8 3755 3757 O
an 9 11 3758 3760 O
unknown 12 19 3761 3768 O
but 20 23 3769 3772 O
potential 24 33 3773 3782 O
risk 34 38 3783 3787 O
for 39 42 3788 3791 O
adverse 43 50 3792 3799 O
events 51 57 3800 3806 O
in 58 60 3807 3809 O
nursing 61 68 3810 3817 O
infants 69 76 3818 3825 O
, 76 77 3825 3826 O
breastfeeding 78 91 3827 3840 O
should 92 98 3841 3847 O
be 99 101 3848 3850 O
discontinued 102 114 3851 3863 O
if 115 117 3864 3866 O
the 118 121 3867 3870 O
mother 122 128 3871 3877 O
is 129 131 3878 3880 O
treated 132 139 3881 3888 B-treatment
with 140 144 3889 3893 I-treatment
Ontak 145 150 3894 3899 I-treatment

total 0 5 3900 3905 B-clinical_variable
bilirubin 6 15 3906 3915 I-clinical_variable
â‰¤ 16 17 3916 3917 O
2.0 18 21 3918 3921 B-upper_bound
mg 22 24 3922 3924 I-upper_bound
/ 24 25 3924 3925 I-upper_bound
dl 25 27 3925 3927 I-upper_bound

total 0 5 3928 3933 B-clinical_variable
white 6 11 3934 3939 I-clinical_variable
blood 12 17 3940 3945 I-clinical_variable
cell 18 22 3946 3950 I-clinical_variable
count 23 28 3951 3956 I-clinical_variable
> 29 30 3957 3958 O
2,500 31 36 3959 3964 B-lower_bound
/ 36 37 3964 3965 I-lower_bound
mm3 37 40 3965 3968 I-lower_bound

